| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1444 | |
| Phytochemical name or plant extracts | Phlomis viscosa Poiret extract | |
| PMID | 30353767 | |
| Literature evidence | A significant anti-cancer effect of the whole extract on U-87 (human glioblastoma carcinoma cells line) and MCF7 (human breast carcinoma cell line) was also demonstrated, and it was better than that of DOX (doxorubicin). | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Ethanolic extract | |
| Source of phytochemicals or plant Extracts | Phlomis viscosa Poiret | |
| Geographical availability | Lebanon-Syria, Palestine, Turkey | |
| Plant parts | NA | |
| Other cancers | Breast cancer, Glioma | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | A significant anti-cancer effect of the whole extract on U-87 (human glioblastoma carcinoma cells line) and MCF7 (human breast carcinoma cell line) was also demonstrated, and it was better than that of DOX (doxorubicin). Collectively, the results obtained in the in vitro models suggest a wide spectrum of beneficial bioactivities of the extract and its active compounds. | |
| Cell line/ mice model | U-87, MCF-7, HEK293 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:454109-1 | |
| Safety | NA |